PEPG
PepGen Ltd
NASDAQ: PEPG · HEALTHCARE · BIOTECHNOLOGY
$1.55
-1.90% today
Updated 2026-04-29
Market cap
$109.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.12
Dividend yield
—
52W range
$1 – $8
Volume
1.5M
PepGen Ltd (PEPG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-885000.00 | $-1.65M | $-22.60M | $-59.27M | $-69.00M | $-82.37M | $-81.64M |
| Capital expenditures | $29000.00 | $8000.00 | $500000.00 | $3.75M | $2.60M | $497000.00 | $264000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $119000.00 | $1.53M | $4.76M | $7.05M | $11.46M | $10.61M |
| Free cash flow | $-914000.00 | $-1.66M | $-23.10M | $-63.02M | $-71.60M | $-82.87M | $-81.90M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $49.17M | — | — | — |